Healthcare focus Lumira Ventures is a healthcare and life sciences focused venture capital firm actively funding and partnering with mission-driven entrepreneurs, presenting opportunity to offer portfolio support services, co-investment discussions, and deal-sourcing collaborations with biotech, medtech, and pharmaceutical accelerators.

Recent fundraises Active engagement in Cancer Breakthrough Fund and collaboration with Canadian Cancer Society and Terry Fox Foundation indicate potential for strategic partnerships in oncology and rare disease areas, offering a path to co-investment and portfolio expansion.

Strategic leadership Leadership evolution to Executive Chairman and ongoing executive-level engagement suggests openness to strategic advisory roles, board seats, and senior talent placements within portfolio companies to accelerate growth and governance.

Portfolio activity Recent investments across medtech and biopharma including Nervonik, Contraline, and other life sciences ventures indicate a steady appetite for scalable devices and novel therapies, signaling opportunities for co-investments, technology licensing, and collaboration on clinical development strategies.

Industry events Active participation in industry events like Invest in BC and MedTech M&A strategy discussions provides windows for outreach, partner matchmaking, and thought-leadership positioning to generate deal flow and alliance opportunities with strategic buyers and researchers.